Testimonial - BioCortex
Our team of experienced scaleup portfolio CFOs have supported BioCorteX since early 2023 assisting with capital planning, working with founders to navigate board and investor conversations and are now supporting them through their Series A.
Our flexible model allows BioCortex to dial up and down as their requirements change. All the benefits of a seasoned CFO at a fraction of the cost.
BioCortex
We first started working with BioCorteX in January 2023 not long after their initial seed round funded by Hoxton Ventures and Sofinnova Partners. We helped set up the finance function working with external accountants ensuring they had coverage in both the UK and USA after executing on a top co flip in early 2023.
EmergeOne has helped the business plan and manage cash flow and built out financial models to support the ongoing business as well as to support the company’s fundraising activities. We worked with BioCorteX’s Australian accountants to secure R&D credits there and work on other financial and commercially strategic matters such as contract review, board reporting and participation alongside investor management and reporting.
“
I founded EmergeOne because I strongly believe access to knowledge & experience around finance shouldn’t be a barrier to growth. Too many external providers are focused on the operational, or are too hands off in their approach, at a price point that is prohibitive for startups. I knew that with the right squad of CFOs we could deliver startups the services they need when they most need them, fuelling their growth and helping them to scale.
Aarish Shah
Founder, EmergeOne
